Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Summary

This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in patients with painful bone metastases.

Timeline

Start

2025-10-21

Primary completion

2027-04-26

Completion

2027-07-05

Drugs

Indications